AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2018
Jun 13, 2018
29821_dirs_2018-06-13_0fb09827-ebbd-4574-b7cf-4914ff39d2e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-06-11
Reporting Person: Ballinger Kevin J. (EVP & Pres, Interven Cardio)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-11 | Common Stock | M | 37430.0000 | $7.3900 | Acquired | 108581.0000 | Direct |
| 2018-06-11 | Common Stock | M | 31056.0000 | $7.1600 | Acquired | 139637.0000 | Direct |
| 2018-06-11 | Common Stock | S | 700.0000 | $36.7700 | Disposed | 138937.0000 | Direct |
| 2018-06-11 | Common Stock | S | 31056.0000 | $32.0000 | Disposed | 107881.0000 | Direct |
| 2018-06-11 | Common Stock | S | 36730.0000 | $35.8702 | Disposed | 71151.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-11 | Stock Option (Right to Buy) | $7.1600 | M | 31056.0000 | Disposed | 2021-02-28 | Common Stock (31056.0000) | Direct |
| 2018-06-11 | Stock Option (Right to Buy) | $7.3900 | M | 37430.0000 | Disposed | 2023-02-28 | Common Stock (37430.0000) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F3: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.63 to $36.445, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
F5: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.